Chapter 1. Research Background
1.1. Research Objectives
1.2. Market Definition
1.3. Research Scope
1.3.1. Market Segmentation by Type
1.3.2. Market Segmentation by Application
1.3.3. Market Segmentation by Geography
1.3.4. Analysis Period
1.4. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.2.1. Breakdown of Primary Research Respondents
2.2.1.1. By region
2.2.1.2. By industry participants
2.2.1.3. By company type
2.3. Market Size Estimation
2.4. Market Breakdown and Data Triangulation
2.5. Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1. Market Segmentation
4.1.1. Overview by Type
4.1.1.1. Surgical sutures and staples
4.1.1.1.1. Surgical sutures
4.1.1.1.2. Surgical staples
4.1.1.2. Surgical hand-held instruments
4.1.1.2.1. Scalpels
4.1.1.2.2. Forceps and spatulas
4.1.1.2.3. Scissors
4.1.1.2.4. Dilators
4.1.1.2.5. Retractors
4.1.1.2.6. Others
4.1.1.3. Electrosurgical devices
4.1.1.4. Others
4.1.2. Overview by Application
4.1.2.1. Neurosurgery
4.1.2.2. Plastic and reconstructive surgeries
4.1.2.3. Wound closure
4.1.2.4. Cardiovascular
4.1.2.5. Orthopedic surgery
4.1.2.6. Microvascular
4.1.2.7. Urology
4.1.2.8. Thoracic surgery
4.1.2.9. Laparoscopy
4.1.2.10. Obstetrics and gynecology
4.1.2.11. Others
4.2. Value Chain Analysis
4.3. Market Dynamics
4.3.1. Trends
4.3.2. Drivers
4.3.2.1. Impact analysis of drivers on market forecast
4.3.3. Restraints
4.3.3.1. Impact analysis of restraints on market forecast
4.3.4. Opportunities
4.4. Porter’s Five Forces Analysis
Chapter 5. Market Size and Forecast by Type
5.1. Surgical Sutures and Staples
5.1.1. Surgical sutures
5.1.2. Surgical staples
5.2. Surgical Hand-Held Instruments
5.2.1. Scalpels
5.2.2. Forceps and spatulas
5.2.3. Scissors
5.2.4. Dilators
5.2.5. Retractors
5.2.6. Others
5.3. Electrosurgical Devices
5.4. Others
Chapter 6. Market Size and Forecast by Application
6.1. Neurosurgery
6.2. Plastic and Reconstructive Surgeries
6.3. Wound Closure
6.4. Cardiovascular
6.5. Orthopedic Surgery
6.6. Microvascular
6.7. Urology
6.8. Thoracic Surgery
6.9. Laparoscopy
6.10. Obstetrics and Gynecology
6.11. Others
Chapter 7. Market Size and Forecast by Geography
7.1. North America Surgical Equipment Market
7.1.1. By Type
7.1.2. By Application
7.1.3. By Country - U.S. and Canada
7.2. Europe Surgical Equipment Market
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country - Germany, France, U.K. and Rest of the Europe
7.3. Asia-Pacific Surgical Equipment Market
7.3.1. By Type
7.3.2. By Application
7.3.3. By Country - China, Japan, India and Rest of the Asia-Pacific
7.4. Latin America Surgical Equipment Market
7.4.1. By Type
7.4.2. By Application
7.4.3. By Country - Brazil and Rest of the Latin America
7.5. Middle East & Africa Surgical Equipment Market
7.5.1. By Type
7.5.2. By Application
Chapter 8. Competitive Landscape
8.1. Competitive Analysis of Key Players
8.2. Global Strategic Developments
Chapter 9. Company Profiles
9.1. Aspen Surgical Products, Inc.
9.1.1. Business Overview
9.1.2. Product and Service Offerings
9.1.3. Key Financial Summary
9.1.4. Strategic Growth Plan
9.2. Medtronic Inc.
9.2.1. Business Overview
9.2.2. Product and Service Offerings
9.2.3. Key Financial Summary
9.2.4. Strategic Growth Plan
9.3. CONMED Corporation
9.3.1. Business Overview
9.3.2. Product and Service Offerings
9.3.3. Key Financial Summary
9.3.4. Strategic Growth Plan
9.4. Stryker Corporation
9.4.1. Business Overview
9.4.2. Product and Service Offerings
9.4.3. Key Financial Summary
9.4.4. Strategic Growth Plan
9.5. Ethicon Inc. (Johnson and Johnson)
9.5.1. Business Overview
9.5.2. Product and Service Offerings
9.5.3. Key Financial Summary
9.5.4. Strategic Growth Plan
9.6. CareFusion Corporation (Becton, Dickinson And Company)
9.6.1. Business Overview
9.6.2. Product and Service Offerings
9.6.3. Key Financial Summary
9.6.4. Strategic Growth Plan
9.7. Smith and Nephew Plc
9.7.1. Business Overview
9.7.2. Product and Service Offerings
9.7.3. Key Financial Summary
9.7.4. Strategic Growth Plan
9.8. B. Braun Melsungen AG
9.8.1. Business Overview
9.8.2. Product and Service Offerings
9.8.3. Key Financial Summary
9.8.4. Strategic Growth Plan
9.9. Boston Scientific Corporation
9.9.1. Business Overview
9.9.2. Product and Service Offerings
9.9.3. Key Financial Summary
9.9.4. Strategic Growth Plan
9.10. Integra LifeSciences Holdings Corporation
9.10.1. Business Overview
9.10.2. Product and Service Offerings
9.10.3. Key Financial Summary
9.10.4. Strategic Growth Plan
9.11. Zimmer Biomet Holdings Inc.
9.11.1. Business Overview
9.11.2. Product and Service Offerings
9.11.3. Key Financial Summary
9.11.4. Strategic Growth Plan
9.12. KLS Martin Group
9.12.1. Business Overview
9.12.2. Product and Service Offerings
9.12.3. Key Financial Summary
9.12.4. Strategic Growth Plan
9.13. Medicon
9.13.1. Business Overview
9.13.2. Product and Service Offerings
9.13.3. Key Financial Summary
9.13.4. Strategic Growth Plan
9.14. ERBE Elektromedizin GmbH
9.14.1. Business Overview
9.14.2. Product and Service Offerings
9.14.3. Key Financial Summary
9.14.4. Strategic Growth Plan
*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.
Chapter 10. Appendix
10.1. Abbreviations
